UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

Leukemia, 2018-03, Vol.32 (3), p.645-653

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival analysis in hematologic malignancies: recommendations for clinicians

Haematologica (Roma), 2014-09, Vol.99 (9), p.1410-1420

2014

Link zum Volltext

Verfügbarkeit prüfen

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Leukemia, 2015-02, Vol.29 (2), p.329-336

2015

Link zum Volltext

Verfügbarkeit prüfen

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Leukemia, 2013-01, Vol.27 (1), p.142-149

2013

Link zum Volltext

Verfügbarkeit prüfen

Harms and benefits of lymphocyte subpopulations in patients with acute stroke

Neuroscience, 2009-02, Vol.158 (3), p.1174-1183

2009

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

Haematologica (Roma), 2014-10, Vol.99 (10), p.1599-1604

2014

Link zum Volltext

Verfügbarkeit prüfen

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

Leukemia, 2013-05, Vol.27 (5), p.1100-1106

2013

Link zum Volltext

Verfügbarkeit prüfen

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Leukemia, 2007-05, Vol.21 (5), p.956-964

2007

Link zum Volltext

Verfügbarkeit prüfen

The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells

Leukemia, 2015-01, Vol.29 (1), p.96-106

2015

Link zum Volltext

Verfügbarkeit prüfen

The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells

Haematologica (Roma), 2013-11, Vol.98 (11), p.1739-1747

2013

Link zum Volltext

Verfügbarkeit prüfen

Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation

Bone marrow transplantation (Basingstoke), 2020-09, Vol.55 (9), p.1860-1861

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma

Annals of oncology, 2017-11, Vol.28 (11), p.2799-2805

2017

Link zum Volltext

Verfügbarkeit prüfen

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma

Annals of oncology, 2006-10, Vol.17 (10), p.1539-1545

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of four prognostic scores in peripheral T-cell lymphoma

Annals of oncology, 2011-02, Vol.22 (2), p.397-404

2011

Link zum Volltext

Verfügbarkeit prüfen

BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells

Leukemia, 2008-09, Vol.22 (9), p.1712-1720

2008

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system involvement in mantle cell lymphoma

Annals of oncology, 2008-01, Vol.19 (1), p.135-141

2008

Link zum Volltext

Verfügbarkeit prüfen

Lack of transient receptor potential vanilloid 1 channel modulates the development of neurogenic bladder dysfunction induced by cross-sensitization in afferent pathways

Journal of neuroinflammation, 2013-01, Vol.10 (1), p.3-3, Article 772

2013

Link zum Volltext

Verfügbarkeit prüfen

TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of action and resistance to monoclonal antibody therapy

Seminars in oncology, 2003-08, Vol.30 (4), p.424-433

2003

Link zum Volltext

Verfügbarkeit prüfen

MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS

Hematological oncology, 2019-06, Vol.37 (S2), p.186-187

2019

Link zum Volltext

Verfügbarkeit prüfen

Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia

Leukemia, 2013-07, Vol.27 (7), p.1600-1603

2013

Link zum Volltext

Verfügbarkeit prüfen

The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial)

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1404-1407

2016

Link zum Volltext

Verfügbarkeit prüfen

PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE

Hematological oncology, 2019-06, Vol.37 (S2), p.395-397

2019

Link zum Volltext

Verfügbarkeit prüfen

GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS

Hematological oncology, 2019-06, Vol.37 (S2), p.346-347

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(151)
Humans
(146)
Female
(94)
Male
(91)
Biological And Medical Sciences
(81)
Hematology
(80)
Middle Aged
(74)
Medical Sciences
(73)
Adult
(70)
Aged
(65)
Oncology
(48)
Hematologic And Hematopoietic Diseases
(41)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(39)
Prognosis
(35)
Aged, 80 And Over
(32)
Chronic Lymphocytic Leukemia
(32)
Immunophenotyping
(26)
Flow Cytometry
(23)
Leukemia
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(25)
Haematologica
(19)
Blood
(15)
New Zealand Journal Of Geology And Geophysics
(13)
British Journal Of Haematology
(9)
Hematological Oncology
(7)
Sangre
(7)
Annals Of Oncology
(6)
Hemasphere
(6)
The American Journal Of Clinical Nutrition
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

Survival analysis in hematologic malignancies: recommendations for clinicians

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Harms and benefits of lymphocyte subpopulations in patients with acute stroke

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells

The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells

Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation

Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma

Comparison of four prognostic scores in peripheral T-cell lymphoma

BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells

Central nervous system involvement in mantle cell lymphoma

Lack of transient receptor potential vanilloid 1 channel modulates the development of neurogenic bladder dysfunction induced by cross-sensitization in afferent pathways

TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL

Mechanism of action and resistance to monoclonal antibody therapy

MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS

Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia

The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial)

PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE

GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS

Suchergebnisse filtern